Dr Margrette Macfie Moore, MD | |
742 Via Sacra, Farmville, VA 23901-5638 | |
(804) 301-5799 | |
Not Available |
Full Name | Dr Margrette Macfie Moore |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 742 Via Sacra, Farmville, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588822316 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0101247831 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Margrette Macfie Moore, MD 742 Via Sacra, Farmville, VA 23901-5638 Ph: (804) 301-5799 | Dr Margrette Macfie Moore, MD 742 Via Sacra, Farmville, VA 23901-5638 Ph: (804) 301-5799 |
News Archive
The finding, by researchers supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), could provide important clues about the neurobiology of alcohol-drinking behaviors in humans.
Communication Intelligence Corporation, a leading supplier of electronic signature solutions for business process automation in the financial industry and the recognized leader in biometric signature verification, announced today its financial results for the first quarter ended March 31, 2010.
Clinicians from the Veterans Affairs Medical Center in Boise, Idaho, will demonstrate that Leaf Healthcare's new, wireless patient monitoring system can significantly improve a caregiver's pressure ulcer prevention processes. Their presentation will take place at the National Pressure Ulcer Advisory Panel Biennial Conference in Orlando, Fla., this week.
Using evidence found in baby teeth, researchers from The Senator Frank R. Lautenberg Environmental Health Sciences Laboratory and The Seaver Autism Center for Research and Treatment at Mount Sinai found that differences in the uptake of multiple toxic and essential elements over the second and third trimesters and early postnatal periods are associated with the risk of developing autism spectrum disorders (ASD), according to a study published June 1 in the journal Nature Communications.
Probiotics-or "good bacteria"-have been used to treat infant colic with varying success. In a new trial published in the journal Alimentary Pharmacology & Therapeutics, investigators have shown that drops containing a particular probiotic strain (Bifidobacterium animalis subsp. lactis BB-12) reduced the duration of daily crying by more than 50% in 80% of the 40 infants who received the probiotic once daily for 28 days.
› Verified 8 days ago